Healthcare -
Biotechnology - NASDAQ - US
$ 0.9619
-3.81 %
$ 218 M
Market Cap
-3.85
P/E
GOSS - COST OF REVENUE
Cost of Revenue GOSS - Gossamer Bio, Inc.
4.38 M
LAST VALUE
-7.88%
2 YEAR CAGR
71.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR